Cargando…

Recognising Lung Cancer in Primary Care

Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Stephen H., Kennedy, Martyn P. T., Neal, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318240/
https://www.ncbi.nlm.nih.gov/pubmed/30499068
http://dx.doi.org/10.1007/s12325-018-0843-5
_version_ 1783384836823580672
author Bradley, Stephen H.
Kennedy, Martyn P. T.
Neal, Richard D.
author_facet Bradley, Stephen H.
Kennedy, Martyn P. T.
Neal, Richard D.
author_sort Bradley, Stephen H.
collection PubMed
description Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved survival. Therefore, although recent advances in oncology may herald breakthroughs in effective treatment, achieving early diagnosis will remain crucial to obtaining optimal outcomes. This is challenging, as most lung cancer symptoms are non-specific or are common respiratory symptoms which usually represent benign disease. Identification of patients at risk of lung cancer who require further investigation is an important responsibility for general practitioners (GPs). Diagnosis has historically relied upon plain chest X-ray (CXR), organised in response to symptoms. The sensitivity of this modality, however, compares unfavourably with that of computed tomography (CT). In some jurisdictions screening high-risk individuals with low dose CT (LDCT) is now recommended. However uptake remains low and the eligibility for screening programmes is restricted. Therefore, even if screening is widely adopted, most patients will continue to be diagnosed after presenting with symptoms. Achieving early diagnosis requires GPs to maintain an appropriate level of suspicion and readiness to investigate in high-risk patients or those with non-resolving symptoms. This article discusses the early detection of lung cancer from a primary care perspective. We outline risk factors and epidemiology, the role of screening and offer guidance on the recognition of symptomatic presentation and the investigation and referral of suspected lung cancer.
format Online
Article
Text
id pubmed-6318240
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-63182402019-01-14 Recognising Lung Cancer in Primary Care Bradley, Stephen H. Kennedy, Martyn P. T. Neal, Richard D. Adv Ther Review Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved survival. Therefore, although recent advances in oncology may herald breakthroughs in effective treatment, achieving early diagnosis will remain crucial to obtaining optimal outcomes. This is challenging, as most lung cancer symptoms are non-specific or are common respiratory symptoms which usually represent benign disease. Identification of patients at risk of lung cancer who require further investigation is an important responsibility for general practitioners (GPs). Diagnosis has historically relied upon plain chest X-ray (CXR), organised in response to symptoms. The sensitivity of this modality, however, compares unfavourably with that of computed tomography (CT). In some jurisdictions screening high-risk individuals with low dose CT (LDCT) is now recommended. However uptake remains low and the eligibility for screening programmes is restricted. Therefore, even if screening is widely adopted, most patients will continue to be diagnosed after presenting with symptoms. Achieving early diagnosis requires GPs to maintain an appropriate level of suspicion and readiness to investigate in high-risk patients or those with non-resolving symptoms. This article discusses the early detection of lung cancer from a primary care perspective. We outline risk factors and epidemiology, the role of screening and offer guidance on the recognition of symptomatic presentation and the investigation and referral of suspected lung cancer. Springer Healthcare 2018-11-29 2019 /pmc/articles/PMC6318240/ /pubmed/30499068 http://dx.doi.org/10.1007/s12325-018-0843-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Bradley, Stephen H.
Kennedy, Martyn P. T.
Neal, Richard D.
Recognising Lung Cancer in Primary Care
title Recognising Lung Cancer in Primary Care
title_full Recognising Lung Cancer in Primary Care
title_fullStr Recognising Lung Cancer in Primary Care
title_full_unstemmed Recognising Lung Cancer in Primary Care
title_short Recognising Lung Cancer in Primary Care
title_sort recognising lung cancer in primary care
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318240/
https://www.ncbi.nlm.nih.gov/pubmed/30499068
http://dx.doi.org/10.1007/s12325-018-0843-5
work_keys_str_mv AT bradleystephenh recognisinglungcancerinprimarycare
AT kennedymartynpt recognisinglungcancerinprimarycare
AT nealrichardd recognisinglungcancerinprimarycare